Skip to content
Cerbios-Pharma SA
Fostering Value through Innovation
Cerbios-Pharma SA
  • CDMO Services
    • HPAPIs
    • ADCs
    • Proteins & Antibodies
  • Products
    • Drug Substances
    • Finished Dosage Forms
    • Animal Health
  • Competencies
    • Chemical
    • Biological
    • Living Microorganisms
    • Quality System
    • Health Safety & Environment
    • Project Management
  • Company
    • About Cerbios
    • Management Team
    • Facilities
    • Sustainability
    • Certifications
    • Working in Cerbios
  • News & Events
    • News
    • Events
    • Press release
  • Contact
Search:
  • CDMO Services
    • HPAPIs
    • ADCs
    • Proteins & Antibodies
  • Products
    • Drug Substances
    • Finished Dosage Forms
    • Animal Health
  • Competencies
    • Chemical
    • Biological
    • Living Microorganisms
    • Quality System
    • Health Safety & Environment
    • Project Management
  • Company
    • About Cerbios
    • Management Team
    • Facilities
    • Sustainability
    • Certifications
    • Working in Cerbios
  • News & Events
    • News
    • Events
    • Press release
  • Contact

Daily Archives: April 13, 2022

Apr132022

Cerbios announces the near finalization of a new cGMP unit for cytotoxic, a further step towards HPAPIs and ADCs market needs

Discover more
News archives
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017

All the news

Address
Cerbios-Pharma SA
Via Figino 6
CH-6917 Barbengo – Lugano
Social

Find us on:

Linkedin page opens in new windowVimeo page opens in new window
Join our Mailing List
Cerbios-Pharma SA
© 2019-2023 by Cerbios-Pharma SA

DISCLAIMER • PRIVACY POLICY • COOKIE POLICY • CREDITS

Go to Top